STRYKER CORP (SYK) Factsheet
Earnings-call transcript: none · IR deck: cataloged — watch a real agent read these end-to-end →
STRYKER CORP (SYK) Stock Analysis
Analysis from 10-Q filed 2026-10-30. Data as of Q3 2026.
Overall Grade: F (Concerning)
Grade F (Concerning). ROIC 10.0%. FCF margin 17.4%. D/E 0.6x. Source: 10-Q filed 2026-10-30.
| Metric | Value | Context |
|---|---|---|
| ROIC | 10.0% | Near cost of capital |
| FCF Margin | 17.4% | Strong cash generation |
| Debt/Equity | 0.6x | Moderate leverage |
ROIC 10.0% — Top 25% of sector peers. FCF margin 17.4% — Top 25%.
Explore STRYKER CORP: Earnings History | Overview
Programmatic access: Available via MCP at mcp.metricduck.com. Tools for SYK: get_company_overview, get_filing_index (lens: debt_stress, management_outlook, risk_trajectory), get_filing_section, get_metric_history, compare_companies, screen_filing_signals.
Profitability: STRYKER CORP earns 10.0% ROIC, Top 25% in Healthcare
ROIC TTM 10.0%, sector median -7.7%, Top 25%. DuPont: NOPAT margin 14.6% × asset turnover 0.6x. Gross margin 65.3%. Operating margin 20.7%. Source: 10-Q filed 2026-10-30.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 10.0% | Adequate | Above sector median of -7.7% |
| Return on Equity (ROE) | 15.8% | Good | Efficient use of shareholder equity |
| Gross Margin | 65.3% | Excellent | Strong pricing power |
| Operating Margin | 20.7% | Excellent | Efficient operations |
Cash Flow: STRYKER CORP generates $4.6B FCF at 17.4% margin, positive NaN/8 quarters
FCF TTM $4.6B. FCF margin 17.4%, Top 25%. OCF/Net income 1.5x. Positive FCF in NaN/8 trailing quarters. Source: 10-Q filed 2026-10-30.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| Free Cash Flow Margin | 17.4% | Good | Excellent cash conversion |
| Free Cash Flow (TTM) | $4.6B | Good | Positive cash generation |
| OCF/Net Income | 1.5x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
Balance Sheet: STRYKER CORP at 0.6x leverage, 9.3x interest coverage
Debt/Equity 0.6x. Total debt $14.9B, cash & investments $3.3B. Interest coverage 9.3x. Source: 10-Q filed 2026-10-30.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| Debt to Equity | 0.6x | Good | Moderate leverage |
| Net Cash Position | $-11.7B | Warning | Net debt position |
| Interest Coverage | 9.3x | Good | Comfortable debt service |
Valuation: STRYKER CORP trades at 32.8x earnings
P/E 32.8x. EV/Sales 5.0x. FCF yield 3.8%. Dividend yield 1.1%. Source: 10-Q filed 2026-10-30.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| P/E Ratio | 32.8x | Adequate | Premium valuation |
| EV/Sales | 5.0x | Good | Growth premium priced in |
| FCF Yield | 3.8% | Adequate | Lower cash yield |
| Dividend Yield | 1.1% | Adequate | Growth focus over income |
Capital Allocation: STRYKER CORP returns 1.1% shareholder yield, reducing shares 0.4% YoY
Total shareholder yield 1.1% (div 1.1%). Share count -0.4% YoY. Capital returned $1.3B TTM. Source: 10-Q filed 2026-10-30.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| Total Shareholder Yield | 1.1% | Adequate | Dividend + buyback yield combined |
| Share Count Change (YoY) | -0.4% | Adequate | Net share reduction (accretive) |
| Total Capital Returned (TTM) | $1.3B | Good | Dividends + buybacks returned to shareholders |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 10.0% | Top 25% | - |
| Free Cash Flow Margin | 17.4% | Top 25% | 5.7x above |
| Gross Margin | 65.3% | Top 50% | 1.0x above |
| Operating Margin | 20.7% | Top 25% | - |
| Return on Equity (ROE) | 15.8% | Top 50% | - |
| P/E Ratio | 32.8x | N/A | - |
Financial Scorecard
| Metric | SYK | Rating | Sector Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 10.0% | Adequate | Top 25% of sector (median: -7.7%) |
| Free Cash Flow Margin | 17.4% | Good | Top 25% of sector (median: 3.0%) |
| Gross Margin | 65.3% | Excellent | Top 50% of sector (median: 63.8%) |
| Debt to Equity Ratio | 63.6% | Good | Moderate leverage |
| P/E Ratio (Price-to-Earnings) | 32.8x | Adequate | Growth premium |
| Free Cash Flow Yield | 3.8% | Adequate | Moderate yield |
Frequently Asked Questions
Q: What is STRYKER CORP's Return on Invested Capital (ROIC)?
STRYKER CORP (SYK) has a trailing twelve-month Return on Invested Capital (ROIC) of 10.0%. The 8-quarter median ROIC is 9.3% with a improving trend. Sector median -7.7%. Source: 10-Q filed 2026-10-30.
Q: What is STRYKER CORP's Free Cash Flow Margin?
STRYKER CORP (SYK) has a free cash flow margin of 17.4%, generating $4.6 billion in free cash flow over the trailing twelve months. Source: 10-Q filed 2026-10-30.
Q: What is STRYKER CORP's P/E ratio and how does it compare to peers?
STRYKER CORP (SYK) trades at a P/E ratio of 32.8x, which is above the sector median of N/A. EV/Sales 5.0x. FCF yield 3.8%. Source: 10-Q filed 2026-10-30.
Q: Does STRYKER CORP pay a dividend?
STRYKER CORP (SYK) currently pays a dividend yield of 1.1%. Total shareholder yield (dividend + buybacks) 1.1%. Source: 10-Q filed 2026-10-30.
Q: How much debt does STRYKER CORP have?
STRYKER CORP (SYK) has a debt-to-equity ratio of 0.6x with total debt of $14.9 billion. Interest coverage 9.3x. Net debt $11.7 billion. Source: 10-Q filed 2026-10-30.
Q: What is STRYKER CORP's revenue and earnings growth?
STRYKER CORP (SYK) grew revenue by 7.9% year-over-year. EPS +23.4% YoY. Source: 10-Q filed 2026-10-30.
Q: How does STRYKER CORP compare to competitors in Healthcare?
Compared to other companies in Healthcare, STRYKER CORP (SYK) shows: ROIC 10.0%, sector median -7.7% (Top 25%). FCF margin 17.4%, sector median 3.0% (Top 25%). Gross margin 65.3%, 1.5pp above sector median. These rankings are based on MetricDuck's analysis of all Healthcare companies with available SEC filings.
Q: What warning signs should I watch for with STRYKER CORP?
No quantitative warning flags fired for STRYKER CORP (SYK) on margin trend, FCF trend, ROIC trend, or leverage thresholds. Source: 10-Q filed 2026-10-30.
Data Source: Data sourced from 10-Q filed 2026-10-30. TTM metrics as of Q3 2026.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.
This analysis is for informational purposes only and does not constitute investment advice.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms